BAMCO Inc’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-14,572
Closed -$3.06M 342
2016
Q4
$3.06M Sell
14,572
-2,537
-15% -$526K 0.02% 229
2016
Q3
$3.94M Buy
17,109
+3,186
+23% +$779K 0.02% 221
2016
Q2
$3.22M Sell
13,923
-13,355
-49% -$3.08M 0.02% 224
2016
Q1
$7.31M Buy
27,278
+15,526
+132% +$4.44M 0.04% 202
2015
Q4
$3.67M Buy
+11,752
New +$3.5M 0.02% 240

Other funds holding AGN

BAMCO Inc's AGN Position: Q1 2017 in Review

BAMCO Inc sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 14,572 shares — an estimated $3.06M sold.

BAMCO Inc first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $7.31M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • BAMCO Inc reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • BAMCO Inc sold 14,572 Allergan plc shares in Q1 2017, an estimated $3.06M.
  • BAMCO Inc first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • BAMCO Inc's Allergan plc position peaked at $7.31M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on BAMCO Inc's 13F filing for Q1 2017, filed 15 May 2017.